Clinical Trial Update: Comparison of Efficacy and Safety in Patients Switching From MabThera® to Rixathon® in Relapsing-Remitting Multiple Sclerosis

View source ↗

Summary

Clinical trial update evaluating efficacy and safety of switching from MabThera to Rixathon in relapsing-remitting multiple sclerosis; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• MabThera (rituximab)
• Rixathon (rituximab)

Snippet

Sponsor: Uppsala University | Conditions: MS (Multiple Sclerosis), Multiple Sclerosis (MS) - Relapsing-remitting | Status: ACTIVE_NOT_RECRUITING